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Abstract 19 
The use of lignocellulosic biomass as a feedstock for microbial fermentation processes presents 20 
an opportunity for increasing the yield of bioproducts derived directly from glucose.  21 
Lignocellulosic biomass consists of several fermentable sugars, including glucose, xylose, and 22 
arabinose.  In this study, we investigate the ability of an E. coli ∆pgi ∆zwf mutant to consume 23 
alternative carbon sources (xylose, arabinose, and glycerol) for growth while reserving glucose 24 
for product formation.  Deletion of pgi and zwf was found to eliminate catabolite repression as 25 
well as the ability of E. coli to consume glucose for biomass formation.  In addition, the yield 26 
from glucose of the bioproduct D-glucaric acid was significantly increased in a ∆pgi ∆zwf strain. 27 
 28 
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1. Introduction 35 
In recent years, concerns over declining petroleum reserves and climate change due to 36 
atmospheric carbon dioxide accumulation have spurred significant interest in using alternative 37 
feedstocks for the manufacture of petroleum-derived products.  Because it is renewable and 38 
abundant, non-food plant (lignocellulosic) biomass represents a promising alternative feedstock 39 
to crude oil.  Moreover, because plants assimilate carbon dioxide during growth, the use of plant-40 
based feedstocks could potentially slow the accumulation of carbon dioxide in the atmosphere.  41 
Recent research has focused heavily on the identification of ideal plant biomass feedstocks 42 
(Joyce and Stewart, 2012), the determination of commercially valuable, biomass-derived 43 
products (Werpy and Petersen, 2004), and the development of processes for converting plant 44 
biomass into these products of interest. 45 
One such process that has received heavy attention is microbial fermentation.  A significant 46 
portion of lignocellulosic biomass consists of fermentable sugars such as glucose, xylose, 47 
arabinose, and galactose (Joyce and Stewart, 2012), and many microbes are naturally able to 48 
convert these sugars into products of interest such as biochemicals  and biopolymers (Lee, 1996).  49 
In addition, microbes can be engineered to produce a wide array of non-natural products via 50 
recombinant DNA technology (Curran and Alper, 2012).  A few products, including D-glucaric 51 
acid (Moon et al., 2009) and D-gluconic acid (Rogers et al., 2006), are derived directly from 52 
glucose; however, microbial production of these products generally suffers from low yields, as a 53 
portion of the glucose feed is utilized to generate cell biomass.  For products such as these that 54 
do not require further glucose metabolism through the canonical reduction pathways, eliminating 55 
the ability to utilize glucose for growth may address this limitation.  We thus set out to design an 56 
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4 
E. coli production platform that utilizes an alternative carbon source such as arabinose or xylose 57 
for cell growth, reserving glucose solely for product generation to maximize yield. 58 
The main pathways for glucose utilization in E. coli are depicted in Figure 1.  Glucose enters 59 
the cell through the phosphotransferase system (PTS) encoded by ptsG and ptsHI-crr and is 60 
phosphorylated to glucose-6-phosphate in the process.  Glucose-6-phosphate can then proceed 61 
through the Entner-Dudoroff Pathway via zwf or through the Embden-Meyerhoff-Parnas 62 
Pathway via pgi.  The carbon in glucose-6-phosphate can also be stored as glycogen via pgm.  63 
Previous work to engineer E. coli for co-utilization of glucose and alternative carbon sources 64 
involved deleting the PTS system (Balderas-Hernández et al., 2011; Solomon et al., 2013; Wang 65 
et al., 2011).  By eliminating the PTS system, catabolite repression can be eliminated, allowing 66 
simultaneous uptake of glucose and a secondary carbon source.  However, these strategies also 67 
eliminate E. coli’s primary method of glucose uptake, and the cell must rely on nonspecific 68 
transporters to import glucose into the cell.  Subsequent phosphorylation of glucose to glucose-6-69 
phosphate via ATP-dependent glk is also required for glucose metabolism in PTS-deficient E. 70 
coli.  Overexpression of the galactose:H
+
 symporter galP and upregulation of glk has been 71 
shown to recover wild-type growth rates in PTS-deficient strains of E. coli (Hernández-Montalvo 72 
et al., 2003).  However, because glycolytic pathways remain intact in this strain, it is likely that 73 
product yields on glucose would remain low.  In this study, we explore the behavior of an E. coli 74 
strain which lacks pgi and zwf and investigate this strain’s ability to produce a glucose-derived 75 
product when supplemented with L-arabinose and D-xylose, sugars which are readily available 76 
from biomass.  Glycerol is also explored as a carbon source, as its price has dropped significantly 77 
in recent years due to significant increases in biodiesel production (Johnson and Taconi, 2009).  78 
Previous work has demonstrated improved yield of glucose-derived products in a ∆pgi ∆zwf 79 
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5 
strain supplemented with mannitol (Kogure et al., 2007; Pandey et al., 2013); however, the price 80 
of mannitol remains high relative to glycerol and biomass-derived sugars. 81 
Materials and Methods 82 
2.1 E. coli strains and plasmids 83 
E. coli strains, plasmids, and oligonucleotides used in this study are listed in Table I.  All 84 
molecular biology manipulations were performed according to standard practices (Sambrook and 85 
Russell, 2001).  E. coli DH10B was used for transformation of cloning reactions and propagation 86 
of all plasmids.  Strains M2, M2-2, and M3 were constructed by our group previously 87 
(Gonçalves et al., 2013; Shiue and Prather, 2014). Strain M2 was generated via knockout of 88 
endA and recA from E. coli MG1655. Strain M2-2 was generated via knockout of gudD and 89 
uxaC from strain M2 to prevent consumption of D-glucaric and D-glucuronic acids during D-90 
glucaric acid production experiments. Strain M3 was derived from strain M2 via knockout of pgi 91 
and served as an intermediate strain; this strain was not further characterized in this work.  92 
Deletion of zwf from strain M3 was achieved by P1 transduction with Keio collection strain 93 
JW1841-1 as the donor (Baba et al., 2006).  The λDE3 lysogen was then integrated site-94 
specifically into this quadruple knockout strain using a λDE3 Lysogenization Kit (Novagen, 95 
Darmstadt, Germany), generating strain M4 (MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf.  To 96 
prevent E. coli from consuming D-glucuronic and D-glucaric acids, both gudD and uxaC were 97 
deleted from the genome.  Deletion of uxaC was performed with λ-Red mediated recombination 98 
(Datsenko and Wanner, 2000) using pKD46recA (Solomon et al., 2013).  PCR primers 99 
pKD13_uxaC_fwd and pKD13_uxaC_rev (Table 1) were used to amplify the recombination 100 
cassette from pKD13 (Datsenko and Wanner, 2000), and strain M4 harboring pKD46recA was 101 
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transformed with this PCR product.  The kan selection cassette was cured from successful 102 
deletion mutants using FLP recombinase expressed from pCP20, generating strain M5. Similar to 103 
strain M3, strain M5 served as an intermediate strain only and was not further characterized in 104 
this work.  Finally, strain M6 (MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf ∆uxaC ∆gudD) was 105 
generated using the same λ-Red mediated recombination method described above; in this case, 106 
primers pKD13_gudD_fwd and pKD13_gudD_rev were used to amplify the recombination 107 
cassette from pKD13.  pRSFD-IN and pTrc-Udh were constructed by our group previously 108 
(Moon et al., 2009; Yoon et al., 2009). To construct pRSFD-IN-Udh, pRSFD-IN was first 109 
digested with XhoI, end-filled with Klenow enzyme, then digested with EcoRI-compatible MfeI.  110 
pTrc-Udh was then digested with EcoRI and SmaI, and the Udh-containing fragment was ligated 111 
into digested pRSFD-IN to generate pRSFD-IN-Udh. 112 
2.2 Culture conditions 113 
For determination of growth curves, cultures were grown in 250 mL baffled shake flasks 114 
containing 50 mL LB medium supplemented with approximately 10 g/L D-glucose, L-arabinose, 115 
glycerol, and/or D-xylose as indicated in Figures 2-5.  Seed cultures were grown overnight at 116 
30°C and inoculated to an optical density at 600 nm (OD600) of 0.005.  Cultures were incubated 117 
at 30°C, 250 rpm, and 80% relative humidity for 72 hours.  To construct a growth curve, cell 118 
densities were measured at regular time intervals on a DU800 Spectrophotometer (Beckman 119 
Coulter, Pasadena, CA), with more frequent sampling during the exponential growth phase.  For 120 
analysis of metabolite concentrations, samples were taken daily, centrifuged to remove cell 121 
debris, and the supernatants analyzed via high performance liquid chromatography as described 122 
in Section 2.3. 123 
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7 
For glucaric acid production in rich medium, cultures were grown in 250 mL baffled shake 124 
flasks containing 50 mL LB medium supplemented with 10 g/L D-glucose and 10 g/L L-125 
arabinose, 10 g/L glycerol, or 10 g/L D-xylose.  Cultures were induced at inoculation with 0.1 126 
mM β-D-1-thiogalactopyranoside (IPTG).  Ampicillin (100 µg/mL) and kanamycin (30 µg/mL) 127 
were added for plasmid maintenance.  Seed cultures were grown overnight at 30°C in LB 128 
medium supplemented with 10 g/L D-glucose and 10 g/L L-arabinose, 10 g/L glycerol, or 10 g/L 129 
D-xylose and inoculated to an OD600 of 0.005.  Cultures were incubated at 30°C, 250 rpm, and 130 
80% relative humidity for 72 hours.  Adequate aeration for product formation was ensured with 131 
the use of baffled shake flasks.  Samples were taken daily, centrifuged to remove cell debris, and 132 
the supernatants analyzed for metabolite concentrations. 133 
For minimal medium experiments, a modified MOPS-buffered medium was used containing 134 
10 g/L D-glucose, 6 g/L L-arabinose, 6 g/L NH4Cl, 0.4 g/L K2HPO4, 2 mM MgSO4, 0.1 mM 135 
CaCl2, 40 mM MOPS, 4 mM tricine, 50 mM NaCl, 100 mM Bis-Tris, 134 µM EDTA, 31 µM 136 
FeCl3, 6.2 µM ZnCl3, 0.76 µM CuCl2, 0.42 µM CoCl2, 1.62 µM H3BO3, 0.081 µM MnCl2, 137 
carbenicillin (100 µg/mL), and kanamycin (30 µg/ml). Seed cultures were started using a 1:100 138 
dilution from LB and were grown at 30°C for 48 hours in modified MOPS.  Working cultures 139 
were inoculated to an OD600 of 0.02 and induced 32 hours after inoculation with 0.1 mM IPTG.  140 
Cultures were incubated at 30°C, 250 rpm, and 80% relative humidity for 110 hours. Adequate 141 
aeration for product formation was ensured with the use of baffled shake flasks. Samples were 142 
taken periodically, centrifuged to remove cell debris, and the supernatants analyzed for 143 
metabolite concentrations. 144 
2.3 Determination of metabolite concentrations 145 
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8 
D-glucose, L-arabinose, glycerol, D-xylose, and D-glucaric acid were quantified from 146 
culture supernatants using high performance liquid chromatography (HPLC) on an Agilent 147 
Series 1100 or Series 1200 instrument equipped with an Aminex HPX-87H column (300 mm by 148 
7.8 mm; Bio-Rad Laboratories, Hercules, CA).  Sulfuric acid (5 mM) was used as the mobile 149 
phase at 35°C and a flow rate of 0.6 mL/min in isocratic mode.  Compounds were detected and 150 
quantified from 10 µL sample injections using refractive index and diode array detectors.  151 
Reported metabolite concentrations are the average of triplicate samples, and error bars represent 152 
one standard deviation ab ve and below the mean value. 153 
3. Results 154 
In E. coli, glucose is imported into the cell and phosphorylated to glucose 6-phosphate (G6P) 155 
by the phosphotransferase system (PTS).  Glucose metabolism then proceeds through two routes 156 
(Figure 1): the Embden-Meyerhoff-Parnas Pathway via phosphoglucose isomerase (pgi) or the 157 
Entner-Dudoroff Pathway via glucose 6-phosphate dehydrogenase (zwf).  A third route 158 
interconverts glucose 6-phosphate and glucose 1-phosphate via phosphoglucomutase (pgm) for 159 
glycogen storage and accumulation, though flux through this node is typically extremely low 160 
(Chassagnole et al., 2002).  To eliminate native consumption of glucose, both pgi and zwf were 161 
deleted from an MG1655-derived strain.  Growth on M9 minimal medium supplemented with 162 
various carbon sources confirmed that the ∆pgi ∆zwf mutant does not grow on glucose but 163 
retains the ability to utilize other carbon sources (Supplementary Figures 1 and 2). 164 
3.1 Behavior of a ∆pgi ∆zwf mutant 165 
 Cell growth was compared for strains M2 and M4, a ∆pgi ∆zwf mutant in rich medium 166 
supplemented with various carbon sources (Figure 2).  Maximum specific growth rates for each 167 
combination of strain and carbon supplement were also calculated (Table II).  As expected, 168 
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9 
growth of strain M2 was similar for all conditions tested, with similar lag phases and maximum 169 
specific growth rates.  Final cell densities were lower when strain M2 was fed D-glucose, likely 170 
due to increased production of acetate (Figure 3), which has been shown to inhibit cell growth 171 
(Roe et al., 1998).  Growth of strain M4 was also similar for all conditions tested with the 172 
exception of glycerol-supplemented cultures, which displayed a significant lag in growth of 173 
approximately 24 hours.  We hypothesize that this lag corresponds to depletion of the metabolic 174 
precursors provided by LB and a metabolic shift towards gluconeogenic metabolism for growth 175 
on glycerol.  Maximum growth rate, lag time, and final cell densities are similar for strain M4 in 176 
the presence of L-arabinose, glycerol, and D-xylose regardless of whether D-glucose was 177 
supplemented in the growth medium, indicating that substrate consumption was similar in the 178 
presence or absence of D-glucose.  Overall, maximum growth rates of strain M4 were 179 
approximately 70% that of strain M2. 180 
 Concentrations of D-glucose, alternative carbon source, and acetate were measured for each 181 
strain/carbon supplement combination as a function of time (Figure 3).  As expected, the 182 
presence of D-glucose prevents consumption of the alternative carbon source in strain M2 via 183 
catabolite repression.  In contrast, the deletion of pgi and zwf prevents consumption of D-glucose 184 
in strain M4.  Interestingly, deletion of pgi and zwf appears to eliminate catabolite repression in 185 
strain M4, as the presence of D-glucose does not preclude consumption of the alternative carbon 186 
source in this strain. 187 
 This phenomenon is perhaps due to intracellular buildup of glucose-6-phosphate.  Catabolite 188 
repression is mediated by cyclic AMP (cAMP), which is synthesized by adenylate cylcase.  189 
Adenylate cylcase is activated via phosphorylation by EIIA
Glc
, but this phosphorylation can only 190 
occur if EIIA
Glc
 has a phosphate group to donate.  When glucose is being actively imported 191 
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10 
through the PTS system, EIIA
Glc
 donates its phosphate to the incoming glucose, resulting in a 192 
mostly unphosphorylated population of EIIA
Glc
, inactive adenylate cyclase, and a low 193 
concentration of cAMP.  The absence or depletion of glucose from the culture medium leads to a 194 
buildup of phosphorylated EIIA
Glc
, activation of adenylate cyclase, and an increase in cAMP 195 
concentration, eventually leading to the expression of catabolite-repressed genes such as araBAD 196 
and xylAB, which are important for arabinose and xylose metabolism, respectively.  Thus, 197 
catabolite repression occurs when there is active glucose flux into the cell, not simply when 198 
glucose is present in the medium.  In a ∆pgi ∆zwf mutant, the accumulation of glucose-6-199 
phosphate quickly eliminates glucose flux into the cell, resulting in derepression of genes 200 
normally repressed in the presence of glucose. 201 
3.2 D-glucaric acid production in a ∆pgi ∆zwf mutant 202 
D-glucaric acid, a dicarboxylic organic acid, is a naturally occurring product which has been 203 
investigated for a variety of potential applications.  A biosynthetic pathway to D-glucaric acid 204 
from D-glucose has been constructed in E. coli (Moon et al., 2009).  This pathway begins with 205 
glucose-6-phosphate, which is converted to myo-inositol-1-phosphate by myo-inositol-1-206 
phosphate synthase (INO1).  Myo-inositol-1-phosphate is then dephosphorylated by an 207 
endogenous phosphatase to yield myo-inositol, which is oxidized to D-glucuronic acid by myo-208 
inositol oxygenase (MIOX).  Finally, D-glucuronic acid is oxidized to D-glucaric acid by uronate 209 
dehydrogenase (Udh).  Because production of D-glucaric acid requires glucose-6-phosphate, we 210 
hypothesized that the yield of D-glucaric acid could be increased significantly in a ∆pgi ∆zwf 211 
strain. 212 
In supplemented LB, D-glucaric acid yield on glucose is increased in the ∆pgi ∆zwf mutant 213 
nearly 18-fold over an unmutated control supplemented with L-arabinose or D-xylose, while 214 
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11 
yield is increased approximately 9-fold in the ∆pgi ∆zwf strain supplemented with glycerol 215 
(Table III).  Additionally, D-glucaric acid titers are significantly higher in the ∆pgi ∆zwf mutant 216 
(Figure 4 and Table III).  We hypothesize that deletion of pgi and zwf results in higher glucose-6-217 
phosphate pools, allowing INO1 to operate much closer to its maximum activity, which leads to 218 
increased flux through the D-glucaric acid pathway. 219 
 To simulate a lean medium that might be obtained from the hydrolysis of lignocellulosic 220 
biomass, the ∆pgi ∆zwf strain was also tested in a modified MOPS minimal medium containing 221 
10 g/L D-glucose and 6 g/L L-arabinose.  Although the strain grew more slowly under these 222 
conditions, D-glucaric acid titers of 0.40 ± 0.02 g/L were obtained, nearly as much as observed 223 
in supplemented LB (Figure 5).  The yield of D-glucaric acid from glucose was 47%; however, 224 
approximately 0.2 g/L of myo-inositol was also produced, bringing the total yield of G6P-derived 225 
products to 71%. Myo-inositol is produced from G6P as an intermediate during D-glucaric acid 226 
production and has previously been observed to build up in the culture medium under some 227 
conditions (Moon et al., 2009).  Modified MOPS medium containing D-xylose and D-glucose 228 
was also tested, but no growth of the ∆pgi ∆zwf mutant was observed, possibly due to stronger 229 
residual catabolite repression of xylAB in minimal medium.  In modified MOPS medium 230 
supplemented with D-xylose alone, M6 does not produce glucaric acid or myo-inositol, 231 
consistent with the expectation that glucaric acid can only be derived from glucose in a ∆pgi 232 
∆zwf mutant (Supplementary Table 1). 233 
4. Discussion 234 
Traditionally, the main focus of metabolic engineering projects has been on increasing the 235 
final titer of a product of interest, and this approach has been widely successful for high-value 236 
compounds such as pharmaceutical intermediates and therapeutic proteins.  However, increasing 237 
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12 
titers alone may not be sufficient for low-margin, high-volume bioproducts such as commodity 238 
chemicals.  In these cases, product yield becomes an important process consideration, as raw 239 
material costs can be a large percentage of the manufacturing costs.  Strategies which are able to 240 
increase product yield without sacrificing titer would be valuable tools for the metabolic 241 
engineer. 242 
The use of renewable feedstocks such as lignocelluosic biomass for biochemical production 243 
presents an interesting opportunity for increasing the yield of biochemicals derived directly from 244 
glucose: in addition to glucose, lignocellulosic biomass contains several other fermentable sugars 245 
(e.g., xylose and arabinose) which may be used for biomass formation while reserving glucose 246 
solely for product generation.  Because wild-type E. coli preferentially consumes glucose, strain 247 
engineering is necessary to shift the cell’s preference towards alternative carbon sources.  In this 248 
work, we characterized the carbon source preference of a ∆pgi ∆zwf mutant and explored its 249 
ability to improve the yield of D-glucaric acid on D-glucose. 250 
As expected, deletion of pgi and zwf eliminates the cell’s ability to consume D-glucose for 251 
biomass formation.  Catabolite repression is eliminated in this strain as well, as the ∆pgi ∆zwf 252 
mutant is able to consume L-arabinose, glycerol, and D-xylose in the presence of D-glucose.  253 
Because glucose-mediated catabolite repression occurs when glucose transport into the cell is 254 
high, we believe that intracellular buildup of glucose-6-phosphate in the ∆pgi ∆zwf mutant leads 255 
to significantly reduced glucose transport, alleviating catabolite repression.  Interestingly, 256 
introduction of the D-glucaric acid pathway, which should draw down intracellular glucose-6-257 
phosphate pools, does not appear to affect the uptake of alternative carbon sources in the 258 
presence of D-glucose.  We speculate that glucose influx in the presence of INO1 is not high 259 
enough to significantly reduce the levels of phosphorylated EIIA
Glc
 to result in activation of 260 
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13 
catabolite repression.  Because the threshold rate of glucose import necessary for activation of 261 
catabolite repression is unknown, efforts to further increase the activity of INO1 or to introduce 262 
more active glucose consumption pathways should proceed with caution to avoid reactivation of 263 
catabolite repression. 264 
5. Conclusions 265 
In this work, we investigate the behavior of a ∆pgi ∆zwf mutant and its ability to utilize 266 
alternative carbon sources for cell growth while reserving D-glucose for product formation.  This 267 
strain was able to consume L-arabinose, glycerol, and D-xylose even in the presence of D-268 
glucose, and yields of D-glucaric acid on D-glucose were increased 9- to 18-fold in the ∆pgi 269 
∆zwf strain.  Additionally, product titers were also increased, as the initial D-glucaric acid 270 
pathway enzyme was no longer in competition with glycolytic enzymes for glucose-6-phosphate.  271 
Furthermore, the ∆pgi ∆zwf mutant exhibits similar yield increases in minimal medium, 272 
suggesting the strain’s potential in an industrial setting; however, additional investigation is 273 
necessary to fully characterize the strain’s robustness. These gains in product yield should easily 274 
translate to other bioproducts derived from D-glucose, and it is hoped that this strain will help 275 
improve the process economics of these value-added biochemicals.   276 
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Table I: E. coli strains, plasmids, and oligonucleotides used
 
Name Relevant Genotype Reference 
Strains 
  
DH10B F
-
 mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 endA1 
araD139 ∆(ara, leu)7697 galU galK λ-rpsL nupG 
Life Technologies (Carlsbad, CA) 
JW1841-1 F
-
, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), λ
-
, ∆zwf-777::kan, rph-1, 
∆(rhaD-rhaB)568, hsdR514 
CGSC #9537 (Baba et al., 2006) 
MG1655 F
-
 λ
-
 ilvG
-
 frb- 50 rph-1 ATCC #700926 
M2 MG1655(DE3) ∆endA ∆recA (Shiue and Prather, 2014) 
M2-2 MG1655(DE3) ∆endA ∆recA ∆gudD ∆uxaC (Shiue and Prather, 2014) 
M3 MG1655 ∆endA ∆recA ∆pgi (Gonçalves et al., 2013) 
M4 MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf This study 
M5 MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf ∆uxaC This study 
M6 MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf ∆uxaC ∆gudD This study 
   
Plasmids   
pCP20 Rep
a
, Amp
R
, Cm
R
, FLP recombinase expressed by λ pr under control of 
λ cI857 
CGSC #7629 
pKD13 R6Kγ ori, Amp
R
, kan
 
CGSC #7633 
pKD46 R101 ori, repA101
a
, Amp
R
, araC, araBp-λγ-λβ-λexo CGSC #7739 
pKD46recA R101 ori, repA101
a
, Amp
R
, araC, araBp-λγ-λβ-λexo, recA (Solomon et al., 2013) 
pRSFDuet-1 pRSR1030 ori, lacI, Kan
R
 EMD4 Biosciences (Darmstadt, 
Germany) 
pTrc99A pBR322 ori, Amp
R
 (Amann and Brosius, 1985) 
pRSFD-IN pRSFDuet-1 with INO1 inserted into the EcoRI and HindIII sites (Moon et al., 2009) 
pTrc-Udh pTrc99A with Udh from Pseudomonas syringae inserted into the NcoI 
and HindIII sites 
(Moon et al., 2009; Yoon et al., 2009) 
pRSFD-IN-Udh pRSFD-IN with Udh inserted into the MfeI and XhoI sites This study 
pTrc-SUMO-MIOX pTrc99A with SUMO-MIOX (Shiue and Prather, 2014) 
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Oligonucleotides  
pKD13_gudD_fwd  
pKD13_gudD_rev  
pKD13_uxaC_fwd  
pKD13_uxaC_rev  
a
 All oligonucleotides purchased from Sigma-Genosys (St. Louis, MO).  Homologous sequences used for recombination are 
underlined. 
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Table II: Maximum growth rates of various strains in rich medium supplemented with various 
carbon sources. 
Strain
* Alternative Carbon 
Source 
Glucose µmax (hr
-1
) 
M2 
L-Arabinose 
- 1.00 ± 0.01 
+ 1.01 ± 0.06 
Glycerol 
- 0.98 ± 0.02 
+ 0.97 ± 0.04 
D-Xylose 
- 1.00 ± 0.03 
+ 0.87 ± 0.20 
M4 
L-Arabinose 
- 0.65 ± 0.01 
+ 0.66 ± 0.02 
Glycerol 
- 0.66 ± 0.05 
+ 0.68 ± 0.01 
D-Xylose 
- 0.70 ± 0.01 
+ 0.67 ± 0.01 
*
 M2: MG1655(DE3) ∆endA ∆recA; M4: MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf 
 
Table III: D-glucaric acid yields on D-glucose for various carbon sources. 
Strain
* 
Carbon 
D-Glucaric Acid 
Titer (g/L) 
Yield on D-Glucose 
(g/g) 
M2-2 
L-Arabinose in LB 0.13 ± 0.01 0.044 ± 0.002 
Glycerol in LB 0.20 ± 0.02 0.052 ± 0.009 
D-Xylose in LB 0.13 ± 0.01 0.039 ± 0.002 
M6 
L-Arabinose in LB 0.50 ± 0.01 0.76 ± 0.13 
Glycerol in LB 0.81 ± 0.10 0.44 ± 0.04 
D-Xylose in LB 1.19 ± 0.08 0.73 ± 0.03 
L-Arabinose in MOPS 0.40 ± 0.02 0.47 ± 0.25 
*
 M2-2: MG1655(DE3) ∆endA ∆recA ∆gudD ∆uxaC; M6: MG1655(DE3) ∆endA ∆recA ∆pgi 
∆zwf ∆uxaC ∆gudD 
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Figures 
 
Figure 1: Glucose utilization pathways in E. coli. 
 
Figure 2: Growth curves for strains M2 (top row) and M4 (bottom row) in rich medium 
supplemented with L-arabinose (“Ara”, triangles), glycerol (“Gly”, circles), and D-xylose 
(“Xyl”, squares) with D-glucose (“Glc”) absent (open points) or present (filled points).  M2: 
MG1655(DE3) ∆endA recA; M4: MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf. 
 
Figure 3: Carbon source and acetate (“Act”, circles) concentrations in rich medium cultures of 
M2 (filled points, solid line) and M4 (open points, dotted lines) supplemented with L-arabinose 
(“Ara”, triangles), glycerol (“Gly”, inverted triangles), and D-xylose (“Xyl”, diamonds) with D-
glucose (“Glc”, squares) absent (left column) or present (right column).  M2: MG1655(DE3) 
∆endA ∆recA; M4: MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf. 
 
Figure 4: D-glucaric acid production (“Gla”, circles) from D-glucose in strains M2-2 and M6 in 
rich medium.  Cultures contained strain M2-2 or M6 harboring pRSFD-IN-Udh and pTrc-
SUMO-MIOX and were grown in LB supplemented with D-glucose (“Glc”, squares) and L-
arabinose (“Ara”, triangles), glycerol (“Gly”, inverted triangles), or D-xylose (“Xyl”, diamonds).  
M2-2: MG1655(DE3) ∆endA ∆recA ∆gudD ∆uxaC (filled points, solid line); M6: MG1655(DE3) 
∆endA ∆recA ∆gudD ∆uxaC ∆pgi ∆zwf (open points, dotted line). 
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Figure 5: Growth and D-glucaric acid (“Gla”, circles) production from D-glucose in strain M6 
in lean medium.  Cultures contained M6 harboring pRSFD-IN-Udh and pTrc-SUMO-MIOX and 
were grown in modified MOPS minimal medium supplemented with 6 g/L L-arabinose (“Ara”, 
triangles) and 10 g/L D-glucose (“Glc”, squares). M6: MG1655(DE3) ∆endA ∆recA ∆gudD 
∆uxaC ∆pgi ∆zwf. 
 
Graphical TOC: Knockout of pgi and zwf from E. coli prevents the cell from using glucose for 
biomass production, allowing the carbon to be diverted towards bioproducts of interest (e.g., D-
glucaric acid). Alternative carbon sources (e.g., D-xylose, glycerol, and L-arabinose), which may 
be derived from biomass hydrolysis, can be fed for biomass formation. 
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Figure 1 
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Figure 2 
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Figure 5 
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Table I: E. coli strains, plasmids, and oligonucleotides used
 
Name Relevant Genotype Reference 
Strains   
DH10B F
-
 mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 
endA1 araD139 ∆(ara, leu)7697 galU galK λ-rpsL nupG 
Life Technologies (Carlsbad, CA) 
JW1841-1 F
-
, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), λ
-
, ∆zwf-777::kan, 
rph-1, ∆(rhaD-rhaB)568, hsdR514 
CGSC #9537 (Baba et al., 2006) 
MG1655 F
-
 λ
-
 ilvG
-
 frb- 50 rph-1 ATCC #700926 
M2 MG1655(DE3) ∆endA ∆recA (Shiue and Prather, 2014) 
M2-2 MG1655(DE3) ∆endA ∆recA ∆gudD ∆uxaC (Shiue and Prather, 2014) 
M3 MG1655 ∆endA ∆recA ∆pgi (Gonçalves et al., 2013) 
M4 MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf This study 
M5 MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf ∆uxaC This study 
M6 MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf ∆uxaC ∆gudD This study 
   
Plasmids   
pCP20 Rep
a
, Amp
R
, Cm
R
, FLP recombinase expressed by λ pr under 
control of λ cI857 
CGSC #7629 
pKD13 R6Kγ ori, Amp
R
, kan
 
CGSC #7633 
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pKD46 R101 ori, repA101
a
, Amp
R
, araC, araBp-λγ-λβ-λexo CGSC #7739 
pKD46recA R101 ori, repA101
a
, Amp
R
, araC, araBp-λγ-λβ-λexo, recA (Solomon et al., 2013) 
pRSFDuet-1 pRSR1030 ori, lacI, Kan
R
 EMD4 Biosciences (Darmstadt, 
Germany) 
pTrc99A pBR322 ori, Amp
R
 (Amann and Brosius, 1985) 
pRSFD-IN pRSFDuet-1 with INO1 inserted into the EcoRI and HindIII sites (Moon et al., 2009) 
pTrc-Udh pTrc99A with Udh from Pseudomonas syringae inserted into the 
NcoI and HindIII sites 
(Moon et al., 2009; Yoon et al., 
2009) 
pRSFD-IN-Udh pRSFD-IN with Udh inserted into the MfeI and XhoI sites This study 
pTrc-SUMO-MIOX pTrc99A with SUMO-MIOX (Shiue and Prather, 2014) 
   
Oligonucleotides 5’ → 3’ Sequence
a
 
pKD13_gudD_fwd TCCCCGGCTGGACCTTTGACCGTAAACGTCCCGTTTTCGGCCGTCATTGATTCTGAAAAAG
GACATAAATCTGTCAAACATGAGAATTAATTCC 
pKD13_gudD_rev CAACAGGCTATTTTGCGTTTAGCATCAGTCTCAAACCGGCTCCAGATAGAGCCGGTTTTGG
TTTTCTGTCGTGTAGGCTGGAGCTGCTTC 
pKD13_uxaC_fwd AATTGGTGTGATAACTTTGTCAGCATCGCACCATAAGCAAGCTAGCTCACTCGTTGAGAG
GAAGACGAAACTGTCAAACATGAGAATTAATTCC 
pKD13_uxaC_rev AAATCTGCTAAAGCGACCGCGACGTTATCCAGCGCATGGATCTTGATGTATTGCATATCA
ACCCCAGACCGTGTAGGCTGGAGCTGCTTC 
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a
 All oligonucleotides purchased from Sigma-Genosys (St. Louis, MO).  Homologous sequences used for recombination are 
underlined. 
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Table II: Maximum growth rates of various strains in rich medium supplemented with various 
carbon sources. 
Strain
* Alternative Carbon 
Source 
Glucose µmax (hr
-1
) 
M2 
L-Arabinose 
- 1.00 ± 0.01 
+ 1.01 ± 0.06 
Glycerol 
- 0.98 ± 0.02 
+ 0.97 ± 0.04 
D-Xylose 
- 1.00 ± 0.03 
+ 0.87 ± 0.20 
M4 
L-Arabinose 
- 0.65 ± 0.01 
+ 0.66 ± 0.02 
Glycerol 
- 0.66 ± 0.05 
+ 0.68 ± 0.01 
D-Xylose 
- 0.70 ± 0.01 
+ 0.67 ± 0.01 
*
 M2: MG1655(DE3) ∆endA ∆recA; M4: MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf 
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Table III: D-glucaric acid yields on D-glucose for various carbon sources. 
Strain
* 
Carbon 
D-Glucaric Acid 
Titer (g/L) 
Yield on D-Glucose 
(g/g) 
M2-2 
L-Arabinose in LB 0.13 ± 0.01 0.044 ± 0.002 
Glycerol in LB 0.20 ± 0.02 0.052 ± 0.009 
D-Xylose in LB 0.13 ± 0.01 0.039 ± 0.002 
M6 
L-Arabinose in LB 0.50 ± 0.01 0.76 ± 0.13 
Glycerol in LB 0.81 ± 0.10 0.44 ± 0.04 
D-Xylose in LB 1.19 ± 0.08 0.73 ± 0.03 
L-Arabinose in MOPS 0.40 ± 0.02 0.47 ± 0.25 
*
 M2-2: MG1655(DE3) ∆endA ∆recA ∆gudD ∆uxaC; M6: MG1655(DE3) ∆endA ∆recA ∆pgi 
∆zwf ∆uxaC ∆gudD 
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Glucose utilization pathways in E. coli  
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Growth curves for strains M2 (top row) and M4 (bottom row) in rich medium supplemented with L-arabinose 
(“Ara”, triangles), glycerol (“Gly”, circles), and D-xylose (“Xyl”, squares) with D-glucose (“Glc”) absent 
(open points) or present (filled points).  M2: MG1655(DE3) ∆endA recA; M4: MG1655(DE3) ∆endA ∆recA 
∆pgi ∆zwf.  
271x203mm (300 x 300 DPI)  
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Carbon source and acetate (“Act”, circles) concentrations in rich medium cultures of M2 (filled points, solid 
line) and M4 (open points, dotted lines) supplemented with L-arabinose (“Ara”, triangles), glycerol (“Gly”, 
inverted triangles), and D-xylose (“Xyl”, diamonds) with D-glucose (“Glc”, squares) absent (left column) or 
present (right column).  M2: MG1655(DE3) ∆endA ∆recA; M4: MG1655(DE3) ∆endA ∆recA ∆pgi ∆zwf.  
203x266mm (300 x 300 DPI)  
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D-glucaric acid production (“Gla”, circles) from D-glucose in strains M2-2 and M6 in rich medium.  Cultures 
contained strain M2-2 or M6 harboring pRSFD-IN-Udh and pTrc-SUMO-MIOX and were grown in LB 
supplemented with D-glucose (“Glc”, squares) and L-arabinose (“Ara”, triangles), glycerol (“Gly”, inverted 
triangles), or D-xylose (“Xyl”, diamonds).  M2-2: MG1655(DE3) ∆endA ∆recA ∆gudD ∆uxaC (filled points, 
solid line); M6: MG1655(DE3) ∆endA ∆recA ∆gudD ∆uxaC ∆pgi ∆zwf (open points, dotted line).  
178x341mm (300 x 300 DPI)  
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Growth and D-glucaric acid (“Gla”, circles) production from D-glucose in strain M6 in lean medium.  Cultures 
contained M6 harboring pRSFD-IN-Udh and pTrc-SUMO-MIOX and were grown in modified MOPS minimal 
medium supplemented with 6 g/L L-arabinose (“Ara”, triangles) and 10 g/L D-glucose (“Glc”, squares). M6: 
MG1655(DE3) ∆endA ∆recA ∆gudD ∆uxaC ∆pgi ∆zwf.  
250x108mm (300 x 300 DPI)  
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Knockout of pgi and zwf from E. coli prevents the cell from using glucose for biomass production, allowing 
the carbon to be diverted towards bioproducts of interest (e.g., D-glucaric acid). Alternative carbon sources 
(e.g., D-xylose, glycerol, and L-arabinose), which may be derived from biomass hydrolysis, can be fed for 
biomass formation.  
293x227mm (300 x 300 DPI)  
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Supporting Information for Improving Product Yields on D-Glucose in Escherichia coli via 
Knockout of pgi and zwf and Feeding of Supplemental Carbon Sources 
Eric Shiue, Irene M. Brockman, and Kristala L. J. Prather 
 
Supplementary Methods 
Supplementary Table 1: Glucaric acid production by M2-2 and M6 in modified MOPS minimal 
medium with 10 g/L xylose 
Supplementary Figure 1: Growth of strains M2 and M4 in M9 minimal medium supplemented 
with D-glucose, D-xylose, or L-arabinose 
Supplementary Figure 2: Growth of strains M2 and M4 on M9 agar supplemented with D-
glucose, D-xylose, or L-arabinose 
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Supplementary Methods 
For glucaric acid production from xylose, cultures were grown in 250 mL baffled shake 
flasks containing a modified MOPS-buffered medium with 10 g/L D-xylose, 6 g/L NH4Cl, 2 g/L 
K2HPO4, 2 mM MgSO4, 0.1 mM CaCl2, 40 mM MOPS, 4 mM tricine, 50 mM NaCl, 100 mM 
Bis-Tris, 134 µM EDTA, 31 µM FeCl3, 6.2 µM ZnCl3, 0.76 µM CuCl2, 0.42 µM CoCl2, 1.62 µM 
H3BO3, 0.081 µM MnCl2, carbenicillin (100 µg/mL), and kanamycin (30 µg/ml). Seed cultures 
were started using a 1:100 dilution from LB and were grown at 30°C for 24 hours in modified 
MOPS.  Working cultures were inoculated to an OD600 of 0.02 and induced at inoculation with 
0.05 mM IPTG.  Cultures were incubated at 30°C, 250 rpm, and 80% relative humidity for 120 
hours. Samples were taken periodically, centrifuged to remove cell debris, and the supernatants 
analyzed for metabolite concentrations by HPLC. 
For growth measurements of M2 and M4, cultures were grown in M9 minimal medium 
supplemented with 4 g/L of the indicated carbon source (D-glucose, D-xylose, or L-arabinose).  
Seed cultures were started using a 1:100 dilution from LB into M9 with the appropriate carbon 
source.  After growth at 37°C for 24 hours, these seed cultures were used to inoculate a working 
culture of M9 with the same carbon source for growth rate measurement.  As the seed cultures 
for strain M4 did not grow in M9 + glucose, an M9 + xylose starter culture was used to seed the 
M9 + glucose culture for growth rate measurements. For growth on solid medium, M9 cultures at 
OD600~0.2 were diluted 10
3
 or 10
4
 and 100 μl was plated on M9 agar with the same carbon 
source.  For strain M4, a culture in M9 + xylose was used for dilution and plating on M9 glucose 
agar, as the strain did not grow in glucose minimal medium seed cultures. 
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Supplementary Table 1: Glucaric acid production by M2-2 and M6 harboring plasmids pTrc-
SUMO-MIOX and pRSFD-IN-udh in modified MOPS minimal medium with 10 g/L xylose.  
Glucaric acid and myo-inositol production were not detected in M6, as expected due to the 
deletion of pgi and zwf, which prevents xylose flux toward glucose-6-phosphate.  Peaks with 
retention time corresponding to the glucaric acid standard were observed in M2-2 cultures but 
were below the threshold for quantification.  M2-2: MG1655(DE3) ∆endA ∆recA ∆gudD ∆uxaC; 
M6: MG1655(DE3) ∆endA ∆recA ∆gudD ∆uxaC ∆pgi ∆zwf. 
 
M2-2 M6 
OD 
glucaric acid 
(g/L) 
myo-inositol 
(g/L) OD 
glucaric acid 
(g/L) 
myo-inositol 
(g/L) 
72 hours 2.2 ± 0.7 n.d. n.d. 0.25 ± 0.01 n.d. n.d. 
120 hours 6.6 ± 0.2 < 0.1 0.025 ± 0.02 6.6 ± 0.2 n.d. n.d. 
n.d. = not detected  
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Supplementary Figure 1: Growth of M2 (filled symbols) and M4 (open symbols) in M9 
minimal supplemented with D-glucose (“Glc”, squares), D-xylose (“Xyl”, circles), or L-
arabinose (“Ara”, triangles).  M2: MG1655(DE3) ∆endA ∆recA; M4: MG1655(DE3) ∆endA 
∆recA ∆pgi ∆zwf. 
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Supplementary Figure 2: Growth of M2 and M4 on M9 agar supplemented with D-glucose, D-
xylose, or L-arabinose.  (A) M9 agar plates after growth for 48 hours at 37° C.  No growth was 
observed for strain M4 on glucose. Carbon sources (left-right): D-glucose, D-xylose, L-
arabinose.  Strain and dilution (top to bottom): M2 at 10
4
 dilution, M4 at 10
4
 dilution, M4 at 10
3
 
dilution.  (B) Closer view of M4 plates at 10
3
 dilution.  Carbon source (left-right): D-glucose, D-
xylose, L-arabinose.  M2: MG1655(DE3) ∆endA ∆recA; M4: MG1655(DE3) ∆endA ∆recA ∆pgi 
∆zwf. 
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